Imperial Valley News Center
- Written by Judy C. Boughey, M.D.
Rochester, Minnesota - Research has shown that for women with early-stage breast cancer, survival rates are very similar between those who choose to have a lumpectomy followed by radiation therapy and those who choose a mastectomy. Choosing which surgery to have is a very personal decision. It is important to take time to carefully consider your options.
- Written by Dana Sparks
Scottsdale, Arizona - Seasonal affective disorder (SAD) is a type of depression that's related to changes in seasons - SAD begins and ends at about the same times every year. If you're like most people with SAD, your symptoms start in the fall and continue into the winter months, sapping your energy and making you feel moody. Less often, SAD causes depression in the spring or early summer.
- Written by Mayo Clinic Staff
Scottsdale, Arizona - Prescription drug abuse is the use of a prescription medication in a way not intended by the prescribing doctor, such as for the feelings you get from the drug. Prescription drug abuse or problematic use includes everything from taking a friend's prescription painkiller for your backache to snorting or injecting ground-up pills to get high. Drug abuse may become ongoing and compulsive, despite the negative consequences.
- Written by Matthew Carlson, M.D.
Rochester, Minnesota - There are two main reasons why it is important to have hearing loss evaluated as soon as it is recognized: first, to determine the cause and second, to review possible treatment options. Early intervention may be associated with a better outcome, depending on the cause of the hearing loss.
- Written by James M. Steckelberg, M.D.
Imperial, California - Most people who have the flu (influenza) have a mild illness and don't need to see a doctor. Common flu signs and symptoms include:
- Written by Paul Scotti
Jacksonville, Florida - A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with chemotherapy for HER2-positive breast cancer. But that marker - the quantity of tumor-infiltrating lymphocytes (S-TILs) in a biopsy - appears irrelevant when trastuzumab is used.
Page 3020 of 3117